Screening of cancer predisposition syndromes
| العنوان: | Screening of cancer predisposition syndromes |
|---|---|
| المؤلفون: | Haifa Al-Sarhani, Mary-Louise C. Greer, Michael S. Gee, Ravi V. Gottumukkala, Eric L. Tung, Angelo Don S. Grasparil |
| المصدر: | Pediatric Radiology. 52:401-417 |
| بيانات النشر: | Springer Science and Business Media LLC, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | medicine.medical_specialty, Adolescent, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Patient experience, medicine, Humans, Genetic Predisposition to Disease, Radiology, Nuclear Medicine and imaging, Child, Intensive care medicine, Early Detection of Cancer, Genetic testing, Neuroradiology, medicine.diagnostic_test, Cancer predisposition, business.industry, Infant, Syndrome, medicine.disease, Magnetic Resonance Imaging, Penetrance, Li–Fraumeni syndrome, Pediatrics, Perinatology and Child Health, Anxiety, medicine.symptom, Surveillance imaging, business, 030217 neurology & neurosurgery |
| الوصف: | Pediatric patients with cancer predisposition syndromes are at increased risk of developing malignancies compared with their age-matched peers, necessitating regular surveillance. Screening protocols differ among syndromes and are composed of a number of elements, imaging being one. Surveillance can be initiated in infants, children and adolescents with a tumor known or suspected of being related to a cancer predisposition syndrome or where genetic testing identifies a germline pathogenic gene variant in an asymptomatic child. Pre-symptomatic detection of malignant neoplasms offers potential to improve treatment options and survival outcomes, but the benefits and risks of screening need to be weighed, particularly with variable penetrance in many cancer predisposition syndromes. In this review we discuss the benefits and risks of surveillance imaging and the importance of integrating imaging and non-imaging screening elements. We explore the principles of surveillance imaging with particular reference to whole-body MRI, considering the strategies to minimize false-negative and manage false-positive whole-body MRI results, the value of standardized nomenclature when reporting risk stratification to better guide patient management, and the need for timely communication of results to allay anxiety. Cancer predisposition syndrome screening is a multimodality, multidisciplinary and longitudinal process, so developing formalized frameworks for surveillance imaging programs should enhance diagnostic performance while improving the patient experience. |
| تدمد: | 1432-1998 0301-0449 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d045816606eff55605254fe348b4290fTest https://doi.org/10.1007/s00247-021-05023-wTest |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi.dedup.....d045816606eff55605254fe348b4290f |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14321998 03010449 |
|---|